Sub menu

Vaccines

Varivax Refrigerated

Details for Varivax Refrigerated (varicella) vaccine and its components.

Recently added

This page was added on 04 June 2018.

Updates made

This page was updated on [date-counter-updated-date]. View history of updates

Sponsor
Merck Sharp & Dohme (Australia)
Administration route
Subcutaneous injection
Vaccine group
Monovalent vaccines
Description:

Registered for use in people aged ≥12 months.

Monovalent varicella vaccine

Lyophilised powder in a monodose vial with a pre-filled diluent syringe.

Each 0.5 mL reconstituted dose contains:

  • ≥1350 plaque-forming units of live attenuated varicella-zoster virus (Oka/Merck strain)
  • 18 mg sucrose
  • 8.9 mg hydrolysed porcine gelatin
  • 3.6 mg urea
  • 0.36 mg monosodium glutamate monohydrate
  • residual components of MRC-5 cells

Also contains traces of:

  • neomycin
  • bovine serum

For Product Information and Consumer Medicine Information about Varivax visit the Therapeutic Goods Administration website.

Additional vaccine information

For detailed advice on vaccine dosage, administration, contraindications and precautions, and variations from product information, please visit the relevant disease chapter/s.

Related diseases
Varicella (chickenpox)

Page history

Last updated
Last reviewed

Help us improve the Australian Immunisation Handbook

Printed content may be out of date. For up to date information, always refer to the digital version:

https://immunisationhandbook.health.gov.au/vaccines/varivax-refrigerated

All vaccines

Link copied

Link, share or bookmark directly to this section of the page.